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Introduction: After complete local excision of pT1 colorectal cancers, prediction of the absence of lymph-
node involvement represents an interesting perspective in order to avoid unnecessary additional radical
surgery, reducing morbidity, mortality and costs of care.
We aimed to identify independent risk factors predictive of nodal involvement in pT1 colorectal cancer
patients.
Methods: Data regarding depth of submucosal invasion, histological grading, tumour budding and
lymphovascular invasion in a consecutive series of 48 pT1 surgically resected colorectal cancers have
been retrospectively collected and related to the nodal status.
Results: A 12.5% rate of nodal involvement has been found. The poor differentiation was found as the
only independent predictor of nodal metastases in pT1 colorectal cancer (p ¼ 0.01).
Conclusions: Poor differentiation was the only independent signiﬁcant predictor of nodal involvement in
pT1 colorectal tumours. Our and literature’s data conﬁrm that risk factors must be prospectively collected
and reported; further genetic and epigenetic predictive factors have to be investigated in order to
carefully evaluate the needing of major surgery for pT1 colorectal cancer.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A T1 colorectal cancer is deﬁned as an invasive carcinoma that
involves the submucosa layer but do not spread beyond it (TNM
AJCC Cancer Staging Manual 7th edition, 2009).
Despite recent advances and improvement in surgical tech-
niques, mortality and morbidity rates up to 4.5% and 40.4%
respectively have been reported in colorectal cancer surgery.1
In node negative pT1 patients, local excision could achieve the
cure with lower morbidity, mortality and costs and improved
quality of life when compared to radical surgery.
Almost 15% of T1 tumours are reported to have nodal metastases
which are strictly related to disease progression and adverse
outcome; it means that 85% of such patients could be deﬁnitively
treated with local excision (endoscopic or surgical resection)
avoiding major complications and additional costs.2
On this basis, several pathological features have been investi-
gated and reported as potential indicators of adverse outcomesx: þ39 0697254752.
).
ciates Ltd. Published by Elsevier Ltafter conservative management such as minor excision. The most
widely considered parameters are both qualitative (tumour grade,
vascular and lymphatic invasion and tumour budding) and quan-
titative (e.g. Haggitt’s and Kikuchi’s system). Several experiences
with different conclusions on this topic have been reported in
literature.
A careful prediction of the risk of nodal involvement is crucial in
order to select patients who need more aggressive treatment. On
this basis several histopathological features that may correlate with
nodal status have been identiﬁed.
In the present study we describe our experience with identiﬁ-
cation and assessment of pathological risk factors for lymph-node
metastases in pT1 colorectal cancer.
2. Materials and methods
All patients admitted to the Department of Surgery of the Uni-
versity Campus Bio-Medico di Roma who underwent colectomy
and lymphadenectomy for pT1 colorectal carcinoma from 2001 up
to date have been considered eligible in the present study.
Diagnosis of pT1 tumour was obtained after endoscopic poli-
pectomy or radical surgery. Pathological report of pT1 endoscopicd. All rights reserved.
Table 1
Characteristics of study patients.
N Nþ Total
Median Age (Range) 70.5 (40e87) 74.5 (40e80) 71 (40e87)
M/F (%) 20 (88)/22 (87) 3 (12)/3 (13) 23 (47.9)/25 (52.1)
Location
Ascending colon (%) 10 (100) 0 10 (20.8)
Transverse colon (%) 0 1 (100) 1 (2.1)
Descending colon (%) 8 (100) 0 8 (16.7)
Sigmoid colon (%) 15 (75) 5 (25) 20 (41.7)
Rectum (%) 9 (100) 0 9 (18.8)
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to major surgery.
Preoperative chemoradiation was performed only in locally
advanced rectal tumours and was never used with sphyncter-
saving ﬁnality in pT1 rectal cancers. After neo-adjuvant chemo-
radiation, ypT1 lesions were never observed.
Data regarding depth of submucosal invasion, grade of differ-
entiation, lymphovascular invasion and tumour budding were
collected according to the European recommendations by a single
pathologist.3
The depth of submucosal invasion was deﬁned according to
Haggitt’s criteria for polypoid tumours (19 cases), and to Kikuchi’s
system for ﬂat lesions (29 cases).
Grade of differentiation was classiﬁed according to the WHO
classiﬁcation in well (G1), moderately (G2) and poorly differenti-
ated (G3) adenocarcinoma.4
Lymphovascular invasion i.e. tumour cells within small luminal
structures lined by endothelial cells has been reported as absent or
present.
Tumour budding i.e. the presence of small clusters or single
inﬁltrating tumour cells at the front of tumour has been assessed as
absent, low grade (<9 clusters or single cells) or high grade (9
clusters or single cells).5
For patients admitted from 2001 to 2011 a re-examination of
pathological slides was needed aiming to achieve missing data.
Pathological slides of patients from 2011 up to date are routinely
evaluated by the same dedicated pathologist and reported ac-
cording to the above mentioned recommendations.2.1. Statistical analysis
All collected data have been analysed in relation to the nodal
status detected at the surgical specimen’s pathological evaluation.
Differences have been analysed using Pearson’s chi-square test and
two-sided Fisher’s exact test. P value <0.05 has been considered
statistically signiﬁcant; univariate analysis has been performed inTable 2
Correlation between nodal status and analysed prognostic features.
Nodal status
Number of patients (%)
N0/N1 N0/N1
Depth of invasion (Polypoid tumours) Haggitt 1 Haggitt
3 (100)/0 3 (100)
Depth of invasion (Flat tumours) Sm 1 Sm 2
7 (100)/0 4 (100)
Grading Well-moderate Poor
36 (94.7)/2 (5.3) 6 (60)/
Budding Absent/low grade High gr
17/0 25 (80.
Lymphovascular invasion Absent Present
35 (87.5)/5 (12.5) 7 (87.5
a Pearson’s chi-squared test.
b Fisher’s exact test.order to identify any risk factor for lymph-node metastases by lo-
gistic regression analysis.
The Statistical Package for the Social Sciences 17.0 for Windows
(SPSS Inc.) program has been used.3. Results
A total of 48 patients with a median age of 71 years (range 40e
87 years) were suitable for the analysis. There were 23 males
(47.9%) (median age 73 years, range 40e79 years) and 25 females
(52.1%) (median age 70 years, range 40e87 years). In the all series
the median number of lymph-nodes harvested was 19 (range 5e
55). Therewere 6 pN1 (12.5%). Themedian number of positive node
retrieved was 1 (range 1e2). Two patients were lost at follow-up
and 2 died because of other diseases. Among the remaining 44
patients all were free from disease after a median follow up of 46
months (range 1e115). Characteristics of the series are shown in
Table 1.
The relationship between the nodal status with depth of sub-
mucosal invasion, tumour grading, tumour budding, and lympho-
vascular invasion showed that histological differentiation was the
only predictive factor on nodal involvement (p ¼ 0.01) (Table 2).
On logistic regression analysis the tumour grading remained a
statistically signiﬁcant predictor (Odds Ratio [OR] ¼ 12.00; 95% CI,
1.786e80.612; p ¼ 0.01).4. Discussion
In our experience we detected absence of nodal involvement in
presence of well differentiated tumours, as well as in Haggitt 1e2 or
Sm1e2 or absent and low tumour budding. This seems to identify a
low risk subset of patients, but statistical analysis failed to show a
negative predictive value for these features. In opposite, the only
independent factor predictive of lymph-nodes metastases is the
poor differentiation, while the additional factors analysed failed to
show a signiﬁcant correlation with nodal involvement.
Many studies can be found on this topic, with non univocal
results.
One of the ﬁrst paper that systematically analysed the risk fac-
tors for lymphatic involvement in pT1 colorectal cancers was
written by Ueno in 2004.2 In his paper 292 pT1 colorectal tumours
were retrospectively analysed; poor differentiation, lymphovas-
cular invasion and tumour budding were the 3 independent factors
associated with lymph-node metastases. The absence of all these
unfavourable factors was related to a 1% nodal involvement rate. In
presence of 1 or 2e3 of these features, nodal involvement rates of
21% and 36% respectively have been observed. According to Ueno,2N0/N1 N0/N1 p
2 Haggitt 3 Haggitt 4
/0 7 (77.8)/2 (22.2) 3 (75)/1 (25) 0.64a
Sm 3
/0 15 (83.3)/3 (16.7) 0.36a
4 (40) 0.01b
ade
6)/6 (19.4) 0.07b
)/1 (12.5) 1.00b
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entiated ones.
Tumour grading has been reported as predictive of nodal
involvement for pT1 together with other features such as tumour
budding, lymphovascular invasion and depth of submucosal inva-
sion by several Authors.1,2
A systematic review published in 2008 classiﬁed pT1 colorectal
cancer as having a high or low risk of recurrence.8 A low risk cancer
was deﬁned as a completely excised, Haggitt level 1e3 or Kikuchi
Sm1, well differentiated carcinoma in absence of lymphatic or
vascular invasion. A high-risk cancer was deﬁned as a poorly
differentiated, Sm2e3 or with lymphatic or vascular invasion car-
cinoma; extension of the tumour to resection margin always im-
plies high risk. Thus, further factors have been identiﬁed as related
to a poorer outcome such as tumour budding and perineural
invasion.
Chang,9 Huh6 and Salinas7 retrospectively reviewed series of
both pT1 and pT2 patients, respectively with 943, 224 and 82
surgically resected patients, identifying as risk factors the ﬁrst
lymphovascular invasion and poor differentiation, the second
lymphovascular and perineural invasion and the third Sm3 level
and beyond as risk factors for nodal involvement. The latter con-
cludes in rectal cancer population that cut-off between Sm 1e2 and
Sm3 level is more likely to discriminate lymphatic spread than
between T1 and T2.
Tateishi10 retrospectively analysed 322 pT1 colorectal cancer
patients; risk of lymph-node involvement was signiﬁcantly related
to the presence of at least one of the following factors: lymphatic
invasion, poor tumour differentiation, tumour budding or complete
disruption of the muscolaris mucosa due to the tumour invasion.
More recently, Benizri11 on a series of 64 pT1 colorectal tumours
showed how the risk of unfavourable oncological outcome (such as
lymph node metastases or persistence of residual tumour) was
associated to the presence of at least 2 of these factors: no free
margin, lymphovascular invasion, poorly differentiated grade,
Sm2e3 involvement (submucosal invasion greater than 300 mm
from the muscolaris mucosae); thus, lymphovascular invasion was
a predictive factor of lymph-node metastases and residual carci-
noma, but not Sm2e3 invasion. On the basis of these ﬁndings, the
Author proposed an invasive approach to endoscopic removed pT1
in presence of 2 or more of the above mentioned criteria; however,
for patients aged 65 years or younger, with a good performance
status, the surgical resection was legitimate even in presence of a
single criterion.
In a series of 55 pT1 tumours, Kye12 analysed the relation be-
tween the presence of nodal metastases and the following features:
tumour size, depth of submucosal invasion, histologic grade, lym-
phovascular invasion, tumour budding, and microacinar structure.
The tumour budding resulted the only predictive independent
factor for lymph-node metastases.
Similar conclusions have been reported by the Japanese
Kobayashi13 on 68 patients who underwent additional colectomy
after endoscopic mucosal resection for pT1 colorectal cancer. In this
experience, the only independent unfavourable prognostic factor
for nodal metastases is the moderate or poor differentiation;
however, in his opinion, only well differentiated pT1 tumours
without lymphovascular invasion should not be submitted to
additional radical surgery after minor excision. He reported a 3.8%
rate of lymph-nodes metastases in G1 pT1 and 25% in others, but
his series differs from ours since most of the patients are identiﬁed
as G1 (76.5%) and others are analysed together (23.5%); while in our
series, rates of differentiation are 16.7% for G1, 62.5% for G2 and
20.8% for G3.
On the basis of this brief analysis of literature and of our results
we could agree with others Authors that up to date it is not possibleto safely predict risk of nodal metastases in locally endoscopic or
surgical completely resected pT1 tumours. Poor differentiation,
lymphovascular invasion and tumour budding should be consid-
ered risky conditions. Pathologists may be encouraged to include in
their clinical reports data about all of the above-discussed features
according to the European guidelines.
According to most Authors, a positive margin after local excision
should always be considered sufﬁcient to proceed with more
aggressive treatment.
In all the cases of negative margins, risk factors for lymph-node
metastases should be always carefully evaluated. Age, general
health and socio-economic status should be always considered too.
For this reason, the decision making process should be multidis-
ciplinary: pathologist, surgeon, medical oncologist and anaes-
thesiologist may be involved.
In presence of well differentiated, Haggitt 1-Sm1 pT1 which
does not present high tumour budding neither lymphovascular
invasion, a wait and see policy could be considered taking in
account:
a) patients comorbidities;
b) level of compliance to close follow-up regimens;
c) patients age;
d) risk of surgery-related complications.
Our study has some limitations such as its retrospective design
and the small size; however, our series is not selected since all the
pT1 patients in the time span have been analysed.
5. Conclusion
It should be very useful to identify a subset of patients with very
low or absent risk of nodal metastases, but our results, as well as
most of the reported studies, do not allow this conclusion. This is
related not only to the low number of cases, but also to the occa-
sional report of nodal metastases even in low risk patients. This is
why further prospective studies are needed on this topic in order to
identify subset of patients which can beneﬁt of await and see policy
with close follow-up regimens, probably studying genetic and
epigenetic factors more strictly related to tumour spread.
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